Rhythm Pharmaceuticals, Inc.
They are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.
$14.00 - $16.00
Morgan Stanley, BofA Merrill Lynch, Cowen & Co.
To view the prospectus for Rhythm Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277